echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > New research pushes new gene therapy for heart failure to the clinic

    New research pushes new gene therapy for heart failure to the clinic

    • Last Update: 2021-08-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Baylor College of Medicine, Texas Heart Institute and partner institutions are bringing a promising new gene therapy to the clinic


    Published in "Science Translational Medicine, studies have shown that toppling hippos in the heart of the cardiomyocyte signaling pathway in pigs after their heart attack leads to renewal and improved function of the heart tissue compared to the hippo signaling pathway in the pig heart without modification


    Heart failure is still the leading cause of death in the Western world, causing more deaths than all cancers combined


    "One of the interests of my laboratory is to develop methods to heal myocardium through research pathways involved in heart development and regeneration," said Ph.


    Previous studies have shown that when patients with heart failure, the activity of the Hippo signaling pathway increases, and its role is to inhibit heart repair


    "Encouraged by these results, we took the next step to test whether closing the hippo signaling pathway in the pig heart would also help the injured heart recover," said the first author, Dr.


    Before applying gene therapy to humans, the first critical step of translation

    In the current study, the researchers simulated the condition of a human patient with a heart attack in pigs and evaluated the effect of gene therapy that inhibits the hippo signaling pathway on heart recovery


    "The condition of a pig with a heart attack is similar to what you might find in a human patient whose heart aorta is blocked causing a myocardial infarction," Martin explained


    "We are very excited about the results," Liu said


    "Our findings support our goal of continuing human clinical trials," Martin said


    ###


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.